Biotech Analyst Minter, along with Dr. Popovic, Associate Professor of Pediatrics at the Pediatric Alliance Allegheny Health Network will discuss the current treatment strategies for pediatric CAH patients on a conference call to be held on October 2 at 11:30 am hosted by William Blair. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NBIX:
- Neurocrine participates in a conference call with William Blair
- Neurocrine price target raised to $135 from $125 at Barclays
- Neurocrine presenting post hoc data analysis in congenital adrenal hyperplasia
- Biotech Alert: Searches spiking for these stocks today
- Neurocrine’s NDA for Ingrezza granules accepted by FDA
